News & Announcements

ViiV Healthcare, Medicines Patent Pool Extend Licence for Dolutegravir to all Lower Middle-Income Countries

TB Alliance and the Medicines Patent Pool Sign Memorandum of Understanding to Improve Access to TB Medicines in Resource-Limited Nations

The Medicines Patent Pool Statement on the US Food and Drug Administration’s Approval of Tenofovir Alafenamide Combination

Upcoming events

20 July 2016

MPP Consultation with Civil Society during 21st International AIDS Conference
Wednesday – 16:00-18:00: International Conference Centre
Durban, South Africa

 

09 June 2016

MPP Ministerial breakfast during the UN Secretary General’s High-Level Meeting on Ending AIDS
Voluntary Patent Pooling – A model for accelerating access to medicines in low- and middle-income countries and ending AIDS
New York, USA

24-25 May 2016

International workshop: Responsiveness in European patenting practices
MPP’s Associate Council, Maica Trabanco will present the work of the foundation on May 25 at 11am
Munich, Germany

Recent Highlights

Generics Bulletin: “Medicines Patent Pool has potential for wider scope”

Read the article

Expression of Interest

MPP invites Expressions of Interest from potential sub-licensees for the licence to manufacture and sell formulations containing lopinavir and ritonavir. 

MPP Submission to the UN High-Level Panel on Access to Medicines

Read the MPP submission.

MPP Newsletter – January 2016

One licence for a HCV medicine, two new disease areas, four new board members, $120 million in savings: check out MPP’s January newsletter for an update on top initiatives in Q3/Q4 2015.

Global Innovative Financing for the Next Decade

Greg Perry and Philippe Douste-Blazy in Global Health and Diplomacy Magazine